Search

Your search keyword '"Sanders, Rogier W."' showing total 1,177 results

Search Constraints

Start Over You searched for: Author "Sanders, Rogier W." Remove constraint Author: "Sanders, Rogier W."
1,177 results on '"Sanders, Rogier W."'

Search Results

2. CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits

3. Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines

6. Assessing immunogenicity barriers of the HIV-1 envelope trimer

7. A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infection

8. Profound structural conservation of chemically cross-linked HIV-1 envelope glycoprotein experimental vaccine antigens

9. Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individual

11. Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study

12. Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies

13. Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens.

14. Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses

15. Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions

16. Broadening sarbecovirus neutralization with bispecific antibodies combining distinct conserved targets on the receptor binding domain

17. HIV BG505 SOSIP.664 trimer with 3M-052-AF/alum induces human autologous tier-2 neutralizing antibodies

18. Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses

19. Antibody Responses Elicited by Immunization with BG505 Trimer Immune Complexes.

20. Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infection

21. Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens

22. Innate cell markers that predict anti-HIV neutralizing antibody titers in vaccinated macaques

24. Broad and ultra-potent cross-clade neutralization of HIV-1 by a vaccine-induced CD4 binding site bovine antibody

26. Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein

27. Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimers

28. A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike

31. Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate

33. Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients

34. Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection

35. Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responses.

36. Gold Nanoparticle Virus-like Particles Presenting SARS-CoV-2 Spike Protein: Synthesis, Biophysical Properties and Immunogenicity in BALB/c Mice.

37. A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern

38. Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection

42. Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller

43. Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responses

44. Germline-targeting SOSIP trimer immunization elicits precursor CD4 binding-site targeting broadly neutralizing antibodies in infant macaques.

46. Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM

47. COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models

49. Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles

Catalog

Books, media, physical & digital resources